---
title: "SAINTS - Sample size / power calculation"
author: "Helen Dale"
date: "11/07/2022"
output: 
  html_document:
    code_folding: hide
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = TRUE, warning=F, message=F, rsuslts='hide', fig.width=16, fig.height=9)

library(ggplot2)
library(RColorBrewer)
#library(lme4)
#library(lmerTest)
library(gee) # using GEE instead of LMM; fixed intercept in LMM captured some of the effect due to exposure...
library(doParallel)
library(pwr)

args<-commandArgs(T)

if(!is.na(args[1])){
  cat(paste(sep="","Using ",args[1]," cores!\n\n"))
  registerDoParallel(cores=args[1])
}else{
  cat(paste(sep="","Using ",2," cores!\n\n"))
  registerDoParallel(cores=2)
}

set.seed(20200128)

# power parameters
alpha<-0.05
power<-0.8
B<-1e3 # number of simulations


if(is.na(args[2]) | args[2]=="malaria"){
  # simulate data
  simulateDataMalSBA<-function(n,prevBin=0.16,sbaSD=0.4,sbaSlopeMonth=(-0.1),iccSD=0.03,effectSize=0.5,effectSizeSD=0.25,pDropOut=0.2,ageMin=9,ageMax=36){
    # n<-100 # this would yield 2n measurements, each pair of measurements for the n individuals 3 months apart
    # prevBin<-0.26 # malaria prevalence in children 6-60 months, Southern Malawi, MIS 2017 p.43 Fig 4.4, https://dhsprogram.com/pubs/pdf/MIS28/MIS28.pdf
    # sbaSD<-0.4 # Nyirenda et al (2014)
    # sbaSlopeMonth<-(-0.105) # Nyirenda et al (2014)
    # ageMin<-9; ageMax<-36 # Nyirenda et al (2014)
    
    pid<-paste(sep="","p",1:n)
    ages<-runif(n=n,min=ageMin,max=ageMax) 
    binCov<-rbinom(n=2*n,size=1,prob=prevBin) # allows participants to change state for each visit; assumed independent risk at each visit and risk the same at all ages -- both of which may not be entirely realistic...
    
    u<-rnorm(n=n,mean=0,sd=iccSD)
    v<-rnorm(n=n,mean=0,sd=iccSD)
    sba9m<-rnorm(n=n,mean=0,sd=sbaSD)
    
    datSim<-data.frame(pid=rep(pid,2),
                       visit=c(rep(1,n),rep(2,n)),
                       age=c(ages,ages+rnorm(n,mean=3,sd=0.05)), # approximately 3 months between initial recruitment and follow-up but allowing minor deviations from planned visit dates
                       ageSlopeEffectLimit=NA,
                       exposure=ifelse(binCov==1,"exposed","unexposed"),
                       u=rep(u,2),
                       v=rep(v,2),
                       sba9m=rep(sba9m,2),
                       sba=NA)
    
    datSim$exposure<-factor(datSim$exposure,levels=c("unexposed","exposed"))
    datSim$agem9<-datSim$age-9
    
    for(i in 1:nrow(datSim)){
      pid<-datSim$pid[i]
      idx1<-which(datSim$pid==pid & datSim$visit==1)
      idx2<-which(datSim$pid==pid & datSim$visit==2)
      datSim$ageSlopeEffectLimit[idx2]<-ifelse(datSim$exposure[idx1]=="exposed",datSim$age[idx2]-0.5,datSim$age[idx2])
      datSim$ageSlopeEffectLimit[idx1]<-datSim$age[idx1]
    }
    
    datSim$sba<-datSim$sba9m+datSim$u+(sbaSlopeMonth+datSim$v)*(datSim$ageSlopeEffectLimit-9)+rnorm(n=nrow(datSim),mean=effectSize,sd=effectSizeSD)*ifelse(datSim$exposure=="exposed",1,0)
    datSim$sba[datSim$visit==2 & rbinom(n=n,size=1,prob=pDropOut)==1]<-NA
    
    return(datSim)
  }
  
  # detect a change in slope of SBA with age for i) malaria cases, ii) malaria vaccinated, iii) other binary covariates (linear mixed model approach)
  fitGEETestCoeff<-function(dat,alpha=0.05,coefName1="exposureexposed",coefName2=NULL){
    library(gee)
    mod<-gee(sba~agem9*exposure,id=as.factor(pid),data=dat[order(dat$pid,dat$visit),],corstr="exchangeable",na.action=na.omit)
    p1<-2*(1-pnorm(abs(summary(mod)$coefficients[coefName1,"Robust z"])))
    p2<-2*(1-pnorm(abs(summary(mod)$coefficients[coefName2,"Robust z"])))
    
    if(p1<alpha){
      res<-1
    }else{
      res<-0
    }
    
    if(!is.null(coefName2)){
      
      if(p2<alpha){
        res<-c(res,1)
      }else{
        res<-c(res,0)
      }
    }
    
    return(res)
  }
 # malaria infection; prevalence ~16%; try sample sizes 1000, 1500, 2000 and effect sizes 0.05, 0.1, 0.15
  gr<-expand.grid(c(2500),c(0.25),c(0.2))
  #gr<-expand.grid(c(2000, 2500, 3000),c(0.2, 0.225, 0.25, 0.275, 0.3),c(0.2))
  datPow<-data.frame(
    alpha=0.05,
    malariaPrev=0.16,
    effectSize=gr[,2],
    n=gr[,1],
    pDropOut=gr[,3],
    powerShift=NA,
    powerSlope=NA
  )
  
  for(j in 1:nrow(datPow)){
    cat(paste(sep="","## effectSize = ",datPow$effectSize[j],", n = ",datPow$n[j],", pDropOut = ",datPow$pDropOut[j]," ##\n"))
    
    
    res<-foreach(i = 1:B) %dopar% {
     
      datSim<-simulateDataMalSBA(n=datPow$n[j],prevBin=datPow$malariaPrev[j],sbaSD=0.4,sbaSlopeMonth=(-0.1),iccSD=0.03,effectSize=datPow$effectSize[j],effectSizeSD=0.25,pDropOut=datPow$pDropOut[j],ageMin=9,ageMax=36)
      tmp<-fitGEETestCoeff(dat=datSim,coefName1="exposureexposed",coefName2="agem9:exposureexposed",alpha=datPow$alpha[j])
      
      tmp
    }
    
    tmp<-matrix(unlist(res),byrow=T,ncol=2)
    resInt<-tmp[,1]
    resSlp<-tmp[,2]
    
    datPow$powerShift[j]<-sum(resInt)/B
    datPow$powerSlope[j]<-sum(resSlp)/B
    cat(paste(sep="","power to detect a shift in SBA = ",datPow$powerShift[j],", power to detect a change in SBA-age slope = ",datPow$powerSlope[j]," [",datPow$effectSize[j],", ",datPow$n[j],", ",datPow$pDropOut[j],"]\n\n"))
  }
}

datPowMalInf <- datPow
export(datPowMalInf, here("data", "datPowMalInf.RData"))

```


## Common assumptions

* Significance level $\alpha=0.05$.

* Minimum power 80%.

* SBA (log10 change in STm cfu/ml) standard deviation $\sigma_{SBA}=0.4-0.6$; based on [Nyirenda et al (2014), Fig. 4C](https://doi.org/10.1093/infdis/jiu045)

* SBA average slope with age (in months) for Malawian children aged 9-36 months $\beta=\approx-0.1$; based on [Nyirenda et al (2014), text p.61 & Fig. 4C](https://doi.org/10.1093/infdis/jiu045)

* $n$ recruited participants, each followed up approximately 3 months later, yielding $n$ pairs of samples from the same individuals.

* $p_{DropOut}=20\%$


## 1. Power for detecting change in SBA due to malaria infection

This calculation estimates statistical power to detect an average shift (up or down) of $\delta_p$ in SBA as a result of a malaria episode. We also looked at power to detect a change in the slope of SBA with age.

### Assumptions

* Malaria prevalence in Southern Malawi: $p_{mal}=26\%$ (children 6-60 monhts; [MIS 2017](https://dhsprogram.com/pubs/pdf/MIS28/MIS28.pdf), p.43 Fig 4.4)

### Method

There are no ready-to-use sample size formulas for this situation and hence we used simulations to estimate statistical power.

Data were simulated as follows:

For $i=1,\ldots,N$, $j=1,2$:

* $u_i\sim\mathcal{N}(0,0.03)$; random subject specific intercept

* $v_i\sim\mathcal{N}(0,0.03)$; random subject specific slope

* $SBA_{9m,i}\sim\mathcal{N}(0,\sigma_{SBA})$

* $malaria_{i,j}\sim\mbox{Bernoulli}(p_{mal})$

* $age_{i,1}\sim\mbox{Uniform}(9,36)$, $age_{i,2}\sim\mathcal{N}(age_{i,1}+3,0.05)$

* $age^*_{i,j}=age_{i,j}$ if $malaria_{i,1}=0$, $age^*_{i,j}=age_{i,1}-0.5$ if $malaria_{i,1}=1$ 

* $\delta_{i,j}\sim\mathcal{N}(\delta_p,0.25)$

Finally:

$$SBA_{i,j}=SBA_{9m,i}+u_i+(\beta+v_i)(age^*_{i,j}-9)+\delta_{i,j}\cdot malaria_{i,j}$$

The simulated data are then analysed using a Generalised Estimating Equations (GEE) model that accounts for the correlations between observations for the same individual:

$$SBA_{i,j}=\beta_0+\beta_1\cdot(age_{i,j}-1)+\beta_2 \cdot malaria_{i,j}+\beta_3 \cdot malaria_{i,j}\cdot (age_{i,j}-9)+\epsilon_{i,j}$$
with an exchangeable correlation structure, i.e. for all $i$, $(\epsilon_{i,1},\epsilon_{i,2})\sim\mathcal{N}(\mathbf{0},\Sigma)$, $\Sigma=\left({\begin{array}{cc}\sigma^2 & \rho \\ \rho & \sigma^2 \\ \end{array} }\right)$.

For power calculation, we simulated a large number, $B=2,000$, datasets, analysed each as above, then tested $H_0: \beta_2=0$, vs. $H_1: \beta_2\neq 0$. Empirical power was then determined as $power=\frac{\mbox{# times }H_0\mbox{ is rejected}}{B}$. We also did the same for testing $\beta_3$.

Below is an example of the simulated data.

```{r}
datSim<-simulateDataMalSBA(n=1000,prevBin=0.16,sbaSD=0.4,sbaSlopeMonth=(-0.1),iccSD=0.03,effectSize=0.1,effectSizeSD=0.25,pDropOut=0.2,ageMin=9,ageMax=36)
datSim$pid_n <- as.numeric(stringr::str_extract(datSim$pid, "\\d+"))
mod<-gee(sba~agem9*exposure,id=pid_n,data=datSim,corstr="exchangeable")

c1<-col2rgb("steelblue")
c1<-rgb(c1[1],c1[2],c1[3],alpha=75,maxColorValue=255)
c2<-col2rgb("orange")
c2<-rgb(c2[1],c2[2],c2[3],alpha=75,maxColorValue=255)

g<-ggplot(data=datSim[order(datSim$pid_n,datSim$visit),],mapping=aes(x=agem9,y=sba,col=exposure)) +
  geom_point() + 
  geom_line(aes(group=as.numeric(pid_n))) +
  scale_color_manual(values=c(c1,c2)) +
  geom_abline(lwd=1,intercept=coef(mod)["(Intercept)"]+coef(mod)["exposureexposed"],slope=coef(mod)["agem9"]+coef(mod)["agem9:exposureexposed"],col="orange") + 
  geom_abline(lwd=1,intercept=coef(mod)["(Intercept)"],slope=coef(mod)["agem9"],col="steelblue") +
  theme_bw() +
  xlab("age in months") +
  ylab("SBA titre") +
  ggtitle("Example results for one simulation: SBA responses with age by malaria exposure")
print(g)
```

### Results

As the graph below shows, with 2,500 paired samples (blue line), the study would be quite well powered to detect in shifts in SBA of 0.25 or more.

While 0.25 may seem quite a subtle effect, it is worth considering that that is less than the effect of aging by 3 months. 

```{r}
datPowMalInf <- import(here("data", "datPowMalInf.RData"))

g <- ggplot(data=datPowMalInf[datPowMalInf$pDropOut==0.2,],mapping=aes(x=effectSize,y=powerShift,group=as.factor(n),color=as.factor(n))) +
  geom_point(size=2.5) +
  geom_line(lwd=1.5) +
  geom_hline(yintercept=0.8,lwd=1,lty=2,col="darkgrey") + 
  scale_color_manual(values=colorRampPalette(brewer.pal(9,"Spectral"))(length(levels(factor(datPow$n)))),name="number of paired samples") +
  ylab("power") +
  xlab("effect size (shift in average SBA)") +
  ggtitle("Power curves: Impact of malaria on SBA, prev (16%), drop-out (20%)") +
  theme(text=element_text(size=16)) +
  theme_bw()
print(g)
```

The change in slope implied by the way the data was generated (basically if you have malaria at the time of the first measurement, you stop having the benefit of improving SBA via aging) is quite small and power to detect this is very low (the maximum reported power across any scenario was `r 100*max(datPow$powerSlope)`%).


## 2. Power for detecting change in SBA due to malaria vaccination

```{r}
if(is.na(args[2]) | args[2]=="malvacc"){
  
  simulateDataMalVacc<-function(n,prevBin=0.16,dirVE=0.4,indirVE=0.1,vaccCov=0.6,sbaSD=0.4,sbaSlopeMonth=(-0.1),iccSD=0.03,effectSize=0.5,effectSizeSD=0.25,pDropOut=0.2,ageMin=9,ageMax=36){
    # n<-100 # this would yield 2n measurements, each pair of measurements for the n individuals 3 months apart
    # prevBin<-0.26 # malaria prevalence in children 6-60 months, Southern Malawi, MIS 2017 p.43 Fig 4.4, https://dhsprogram.com/pubs/pdf/MIS28/MIS28.pdf
    # sbaSD<-0.4 # Nyirenda et al (2014)
    # sbaSlopeMonth<-(-0.105) # Nyirenda et al (2014)
    # ageMin<-9; ageMax<-36 # Nyirenda et al (2014)
    
    pid<-paste(sep="","p",1:n)
    ages<-runif(n=n,min=ageMin,max=ageMax) 
    binCov<-rbinom(n=2*n,size=1,prob=prevBin) # allows participants to change state for each visit; assumed independent risk at each visit and risk the same at all ages -- both of which may not be entirely realistic...
    
    u<-rnorm(n=n,mean=0,sd=iccSD)
    v<-rnorm(n=n,mean=0,sd=iccSD)
    sba9m<-rnorm(n=n,mean=0,sd=sbaSD)
    
    cluster<-c(rep(c(rep(0,n/2),rep(1,n/2)),2)) # vaccine cluster membership
    vaccTmp<-sample(0:1,size=n/2,replace=T,prob=c(1-vaccCov,vaccCov))
    vaccine<-c(rep(0,n/2),vaccTmp,rep(0,n/2),vaccTmp) # vaccination recipients
    
    protCov<-rep(0,2*n)
    idxIndi<-which(binCov==1 & cluster==1 & vaccine==0)
    idxVacc<-which(binCov==1 & vaccine==1)
    protCov[sample(idxIndi,replace=T,size=round(indirVE*length(idxIndi)))]<-1
    protCov[sample(idxVacc,replace=T,size=round((1-(1-indirVE)*(1-dirVE))*length(idxVacc)))]<-1
    
    datSim<-data.frame(pid=rep(pid,2),
                       visit=c(rep(1,n),rep(2,n)),
                       age=c(ages,ages+rnorm(n,mean=3,sd=0.05)), # approximately 3 months between initial recruitment and follow-up but allowing minor deviations from planned visit dates
                       vaccCluster=cluster,
                       vaccine=vaccine,
                       ageSlopeEffectLimit=NA,
                       exposure=ifelse(binCov==1,"exposed","unexposed"),
                       infection=ifelse(binCov==1 & protCov==0,"infected","uninfected"),
                       u=rep(u,2),
                       v=rep(v,2),
                       sba9m=rep(sba9m,2),
                       sba=NA)
    
    datSim$exposure<-factor(datSim$exposure,levels=c("unexposed","exposed"))
    datSim$infection<-factor(datSim$infection,levels=c("uninfected","infected"))
    datSim$agem9<-datSim$age-9
    
    datSim$ageSlopeEffectLimit[i]<-datSim$age[i]
    
    for(i in 1:nrow(datSim)){
      pid<-datSim$pid[i]
      idx1<-which(datSim$pid==pid & datSim$visit==1)
      idx2<-which(datSim$pid==pid & datSim$visit==2)
      datSim$ageSlopeEffectLimit[idx2]<-ifelse(datSim$infection[idx2]=="infected",datSim$age[idx2]-0.5,datSim$age[i])
    }
    
    datSim$sba<-datSim$sba9m+datSim$u+(sbaSlopeMonth+datSim$v)*(datSim$ageSlopeEffectLimit-9)+rnorm(n=nrow(datSim),mean=effectSize,sd=effectSizeSD)*ifelse(datSim$infection=="infected",1,0)
    datSim$sba[datSim$visit==2 & rbinom(n=n,size=1,prob=pDropOut)==1]<-NA
    
    return(datSim)
  }
  
  fitGEETestCoeffMalVacc<-function(dat,alpha=0.05,coefName1="vaccine",coefName2=NULL){
    library(gee)
    mod<-gee(sba~agem9*exposure+vaccCluster+vaccine,id=as.factor(pid),data=dat[order(dat$pid,dat$visit),],corstr="exchangeable",na.action=na.omit)
    p1<-2*(1-pnorm(abs(summary(mod)$coefficients[coefName1,"Robust z"])))
    p2<-2*(1-pnorm(abs(summary(mod)$coefficients[coefName2,"Robust z"])))
    
    if(p1<alpha){
      res<-1
    }else{
      res<-0
    }
    
    if(!is.null(coefName2)){
      if(p2<alpha){
        res<-c(res,1)
      }else{
        res<-c(res,0)
      }
    }
    
    return(res)
  }
  
  gr<-expand.grid(c(2500),c(0.42,0.5),c(0.1),c(0.5,0.75,1, 1.25, 1.5))
  datPowMalVacc<-data.frame(
    alpha=0.05,
    malariaPrev=0.26,
    effectSize=gr[,4],
    dirVE=gr[,2],
    indirVE=0.1,
    vaccCov=0.6,
    n=gr[,1],
    pDropOut=gr[,3],
    powerDir=NA,
    powerIndir=NA
  )
  
  for(j in 1:nrow(datPowMalVacc)){
    cat(paste(sep="","## direct VE = ",datPowMalVacc$dirVE[j],", n = ",datPowMalVacc$n[j],", pDropOut = ",datPowMalVacc$pDropOut[j],", effectSize = ",datPowMalVacc$effectSize[j]," ##\n"))

    
    res<-foreach(i = 1:B) %dopar% {
      
      datSim<-simulateDataMalVacc(n=datPowMalVacc$n[j],prevBin=datPowMalVacc$malariaPrev[j],sbaSD=0.4,sbaSlopeMonth=(-0.1),iccSD=0.03,effectSize=datPowMalVacc$effectSize[j],effectSizeSD=0.25,pDropOut=datPowMalVacc$pDropOut[j],ageMin=9,ageMax=36,dirVE=datPowMalVacc$dirVE[j],indirVE=datPowMalVacc$indirVE[j],vaccCov=datPowMalVacc$vaccCov[j])
      tmp<-fitGEETestCoeffMalVacc(dat=datSim,coefName1="vaccine",coefName2="vaccCluster",alpha=datPowMalVacc$alpha[j])
    
      tmp
    }
    
    tmp<-matrix(unlist(res),byrow=T,ncol=2)
    resInt<-tmp[,1]
    resSlp<-tmp[,2]
    
    datPowMalVacc$powerDir[j]<-sum(resInt)/B
    datPowMalVacc$powerIndir[j]<-sum(resSlp)/B
    cat(paste(sep="","power to detect vaccine direct effect = ",datPowMalVacc$powerDir[j],", power to detect vaccine indirect effect = ",datPowMalVacc$powerIndir[j]," [",datPowMalVacc$effectSize[j],", ",datPowMalVacc$dirVE[j],", ",datPowMalVacc$n[j],", ",datPowMalVacc$pDropOut[j],"]\n\n"))
  }
  
  save(list=ls(),file="Vacc-iNTS_SampleSize_MalariaVacc.RData")
  
}

export(datPowMalVacc, here("data", "datPowMalVacc.RData"))

```

I find it helpful to keep the following diagram about direct, indirect, overall and total vaccine effects in mind:

![Taken from Shim E., Galvani, A.P (2012), Distinguishing vaccine efficacy and effectiveness, Vaccine, 30, 6700-6705, DOI 10.1016/j.vaccine.2012.08.045](vaccineEffects.png)

### Assumptions

* Malaria prevalence in Southern Malawi: $p_{mal}=26\%$ (children 6-60 monhts; [MIS 2017](https://dhsprogram.com/pubs/pdf/MIS28/MIS28.pdf), p.43 Fig 4.4)

* Vaccination coverage in the vaccine cluster is 60% (I recall that's the number Donnie mentioned on the call; need to confirm).

* Malaria RTS,S/AS01 VE in children 5-17 months, 18 months after vaccination = 42-50% ([10.1371/journal.pmed.1001685](https://doi.org/10.1371/journal.pmed.1001685)). This is the direct VE. 

* $VE = 1-\lambda_v/\lambda_c$ where $\lambda_v,\lambda_c$ are the incidences in vaccinated and control populations. We work with a prevalence here. However: if we assume that malaria infection has a relatively short duration, that the vaccine does not shorten or lengthen the duration of the infection episode, then a drop in incidence of X% must also result in a drop in prevalence of X%. We therefore assume the direct effect of the vaccine results in a 42-50% reduction in malaria prevalence.

* Indirect effect: I just assume this is 10% for now -- NO DATA TO SUPPORT THIS.

* Balanced sampling from the vaccinated and unvaccinated clusters.

* Shift in SBA due to malaria infection = 0.1 - 0.2.

With these assumption we will assume 16.0% malaria prevalence in the non vaccinated cluster, 23.4% malaria prevalence in the non-vaccinated individuals from the vaccinated cluster, 11.7-13.6% malaria prevalence in the vaccinated individuals.

### Method

The simulation model will be largely the same as the one used for calculating power for detecting a shift in SBA due to malaria infection - with the modification that we now also simulate vaccination cluster membership, vaccination status and hence that we have 3 groups with different malaria prevalences.

The analysis model will change to:

$$SBA_{i,j}=\beta_0+\beta_1\cdot(age_{i,j}-1)+\beta_2 \cdot malaria_{i,j}+\beta_3 \cdot malaria_{i,j}\cdot (age_{i,j}-9)+\beta_4\cdot vaccine\_cluster + \beta_5\cdot vaccine + \epsilon_{i,j}$$

The main focus of the analysis would be to test $H_0:\beta_5=0$ vs $H_1:\beta_5\neq 0$; the direct effect of malaria vaccine on SBA. A secondary focus would be to test $\beta_4$, the indirect effect on SBA.


### Results

Power is reduced. However we still reach just about 80% power for large effects of malaria infection on SBA (1 unit change) and assuming 50% vaccine efficacy of RTS,S/AS01. While this is an exploratory aim, we have still adequate power for the upper end of realistic scenarios.

```{r}
datPowMalInf <- import(here("data", "datPowMalInf.RData"))

g<-ggplot(data=datPowMalVacc,mapping=aes(x=dirVE,y=powerDir,group=factor(paste(sep="","ES ",effectSize,", pDropOut ",pDropOut)),color=factor(effectSize,levels=c("0.25","0.5","0.75","1")),lty=factor(pDropOut,levels=c("0.1","0.2")))) +
	geom_point(size=3) +
	geom_line(lwd=1.25) +
	geom_hline(yintercept=0.8,lwd=2,lty=2,col="darkgrey") + 
	scale_color_manual(values=colorRampPalette(brewer.pal(9,"Spectral"))(4),name="Effect size of malaria infection.") +
	scale_linetype_manual(values=c(3,1),name="drop-out proportion") +
	ylab("power") +
	xlab("vaccine efficacy") +
	ggtitle("Power for different effect sizes (increase in SBA) of malaria infection and (direct) vaccine efficacies (for 20% drop-out).") +
	theme(text=element_text(size=16))

print(g)
```


## 3. Power for detecting change in SBA due to Salmonella exposure

### Assumptions

* Salmonella shedding prevalence (i.e. the proportion of individuals which will test positive for Salmonella in stool at a given visit): $p_{sal}=8\%$

### Method

A stool sample will only be collected at the first visit and tested for presence of Salmonella. This allows splitting the data into 2 groups: those who are shedding Salmonella at the first visit and those who do not.

As exposure will have a delayed effect on immunity / SBA, only the second SBA measurement needs to be compared (but can use the SBA measurement from the first visit to adjust for unmeasured latent factors that result in some individuals having naturally higher or lower SBA).

From a sample size / power calculation point of view this means that we can use formulas for simple, unbalanced, two-sample t-tests (technically this assumes an unadjusted analysis, but it is common to do sample size calculations this way: adjustment - if needed - should increase power).

In R we calculate this using the function `pwr.t2n.test()` from the `pwr` package.

### Results

```{r}
gr<-expand.grid(seq(1000,2500,by=100),c(0.1,0.2),c(0.4,0.6),c(1/24,0.074,0.08,0.099))

datPowSalm<-data.frame(
	alpha=0.05,
	prev=gr[,4],
	pDropOut=0.2,
	nTot=gr[,1],
	nTotComp=NA,
	n1=NA,
	n2=NA,
	delta=gr[,2],
	sd=gr[,3],
	es=NA,
	power=NA
)

datPowSalm$nTotComp<-floor((1-datPowSalm$pDropOut)*datPowSalm$nTot)
datPowSalm$n1<-round(datPowSalm$prev*datPowSalm$nTotComp)
datPowSalm$n2<-round((1-datPowSalm$prev)*datPowSalm$nTotComp)
datPowSalm$es<-round(digits=2,datPowSalm$delta/datPowSalm$sd)

for(j in 1:nrow(datPowSalm)){
	datPowSalm$power[j]<-pwr.t2n.test(n1=datPowSalm$n1[j],n2=datPowSalm$n2[j],d=datPowSalm$es[j],sig.level=datPowSalm$alpha[j])$power
}

datPowSalm$EsSd<-factor(paste(sep="","ES = ",datPowSalm$delta,", SD = ",datPowSalm$sd))
```

As the results below show, power is quite high (`r round(digits=2,100*datPowSalm$power[datPowSalm$prev==0.08 & datPowSalm$delta==0.2 & datPowSalm$nTot==2000 & datPowSalm$sd==0.4])`%) for a difference of 0.2 in SBA between the 2 groups, assuming 2,000 individuals, 20% drop-out, $\sigma_{SBA}=0.4$. If SBA has higher variance (e.g. $\sigma=0.6$ rather than $\sigma=0.4$), power will be reduced but still very high (`r round(digits=2,100*datPowSalm$power[datPowSalm$prev==0.08 & datPowSalm$delta==0.2 & datPowSalm$nTot==2000 & datPowSalm$sd==0.6])`% for $\sigma_{SBA}=0.6$).

For smaller effect sizes (difference of 0.1 in SBA) power is lower (see graph).

Note that the sample sizes go up to 2,500 on the graph below. The vertical dashed grey line indicates the 2,000 individuals that are planned to be recruited.

```{r}
ggplot(data=datPowSalm[datPowSalm$prev==0.08,],mapping=aes(x=nTot,y=power,group=EsSd,color=EsSd)) +
	geom_point(size=4) +
	geom_line(lwd=2) +
	scale_color_manual(values=c("steelblue","greenyellow","salmon","orange"),name="effect size and std. dev.") +
	geom_hline(yintercept=0.8,lwd=2,lty=2,col="darkgrey") + 
	geom_vline(xintercept=2000,lwd=2,lty=2,col="darkgrey") +
	theme(legend.position = "right",text=element_text(size=16)) +
	xlab("number of paired samples") +
	ylab("power") +
	ggtitle("Power curves for different effect sizes. Prevalence of exposure = 8%, drop-out = 20%.")
```


## 4. Power for detecting change in seroconversion rates

### Assumptions

* Salmonella shedding prevalence (i.e. the proportion of individuals which will test positive for Salmonella in stool at a given visit): $p_{sal}=8\%$

### Method

This is quite similar to testing for a difference in SBA between 2 groups, but now we compare a binary outcome (seroconversion) between the 2 groups. Additional assumption are be around what proportion of individuals are already seroconverted at the first sample and how many more are seroconverted at the second sample -- we compute several scenarios here.

As before, we will use ready formulas (now for comparing proportions between 2 groups of unequal size), but the actual analysis in the study can be adjusted for e.g. age and other confounders.

### Results

```{r}
gr<-expand.grid(seq(1000,2500,by=100),c(0.1,0.15,0.2,0.25),c(0.2,0.3,0.4,0.5),c(1/24,0.074,0.08,0.099))

datPowSeroConv<-data.frame(
	alpha=0.05,
	prev=gr[,4],
	pDropOut=0.2,
	nTot=gr[,1],
	nTotComp=NA,
	n1=NA,
	n2=NA,
	p1=gr[,2],
	p2=gr[,3],
	power=NA
)

datPowSeroConv$nTotComp<-floor((1-datPowSalm$pDropOut)*datPowSalm$nTot)
datPowSeroConv<-datPowSeroConv[datPowSeroConv$p2/datPowSeroConv$p1<3 & datPowSeroConv$p2/datPowSeroConv$p1>1,]

datPowSeroConv$n1<-round(datPowSeroConv$prev*datPowSeroConv$nTotComp)
datPowSeroConv$n2<-round((1-datPowSeroConv$prev)*datPowSeroConv$nTotComp)
datPowSeroConv$p1p2<-factor(paste(sep="","p1 = ",datPowSeroConv$p1,", p2 = ",datPowSeroConv$p2))

for(j in 1:nrow(datPowSeroConv)){
	datPowSeroConv$power[j]<-pwr.2p2n.test(h=ES.h(p1=datPowSeroConv$p1[j],p2=datPowSeroConv$p2[j]),n1=datPowSeroConv$n1[j],n2=datPowSeroConv$n2[j])$power
}
```

Results below show that power is quite high for most scenarios, particularly when the effect of exposure results in a doubling or more of the seroconversion rate (i.e. p2 $\geq$ 2$\cdot$p1).

Note that the sample sizes go up to 2,500 on the graph below. The vertical dashed grey line indicates the 2,000 individuals that are planned to be recruited.

```{r}
ggplot(data=datPowSeroConv[datPowSeroConv$prev==0.08,],mapping=aes(x=nTot,y=power,group=p1p2,color=p1p2)) +
	geom_point(size=4) +
	geom_line(lwd=2) +
	scale_color_manual(values=colorRampPalette(brewer.pal(9,"Spectral"))(length(levels(datPowSeroConv$p1p2))),name="prop. seroconverted in each group") +
	geom_hline(yintercept=0.8,lwd=2,lty=2,col="darkgrey") + 
	geom_vline(xintercept=2000,lwd=2,lty=2,col="darkgrey") +
	theme(legend.position = "right",text=element_text(size=16)) +
	xlab("number of paired samples") +
	ylab("power") +
	ggtitle("Power curves for different combinations of 3-month seroconversion rates. Prevalence of exposure = 8%, drop-out = 20%.")
```



